Prescription drug · ANDA
Metaxalone NDC 69306-100
Metaxalone 800 mg/1 · Tablet · Oral · Doc Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69306-100-01 | 69306010001 | 100 TABLET in 1 BOTTLE (69306-100-01)Marketed from Apr 1, 2019 | |
| 69306-100-02 | 69306010002 | 20 TABLET in 1 BOTTLE (69306-100-02)Marketed from Jan 1, 2020 | |
| 69306-100-03 | 69306010003 | 30 TABLET in 1 BOTTLE (69306-100-03)Marketed from Dec 13, 2019 | |
| 69306-100-06 | 69306010006 | 60 TABLET in 1 BOTTLE (69306-100-06)Marketed from Dec 13, 2019 | |
| 69306-100-09 | 69306010009 | 90 TABLET in 1 BOTTLE (69306-100-09)Marketed from Dec 13, 2019 | |
| 69306-100-15 | 69306010015 | 15 TABLET in 1 BOTTLE (69306-100-15)Marketed from Jan 1, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metaxalone
- Generic name (nonproprietary)
- metaxalone
- Active ingredients
- Metaxalone — 800 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Doc Rx
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203695
- Marketing start
- Listing expires
- Other FDA classes
- Centrally-mediated Muscle Relaxation (Physiologic effect)
- Identifiers
- Product ID 69306-100_cd0929e3-c3b2-c89a-e053-2a95a90a7b2aSPL ID cd0929e3-c3b2-c89a-e053-2a95a90a7b2aSPL set ID 87518046-c959-d5f3-e053-2a95a90a5f7eRxCUI 351254UNII 1NMA9J598Y
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469306010001followed by a unit qualifier and the quantityPackage 69306-0100-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Metaxalone tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203695
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Direct_Rx | 72189-645 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Proficient Rx LP | 71205-326 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Sportpharm LLC | 85766-011 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0375 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | PHOENIX RX LLC | 85509-2341 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-093 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-8014 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0131 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Asclemed USA, Inc. | 76420-898 |
| Metaxalone | Metaxalone 800 mg/1 | TabletOral | Actavis Pharma, Inc. | 0591-2341 |